Driehaus Capital Management LLC Imago Bio Sciences, Inc. Transaction History

Driehaus Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$14.15 - $19.5 $124,647 - $171,775	-8,809 Reduced 2.5%	343,846 $5.18 Million
Q2 2022 Aug 15, 2022	SELL	$11.81 - $20.92 $27,729 - $49,120	-2,348 Reduced 0.66%	352,655 $4.72 Million
Q1 2022 May 16, 2022	SELL	$16.97 - $25.0 $115,667 - $170,400	-6,816 Reduced 1.88%	355,003 $6.84 Million
Q4 2021 Feb 14, 2022	SELL	$16.22 - $29.69 $288,294 - $527,710	-17,774 Reduced 4.68%	361,819 $8.58 Million
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $6.07 Million - $10.9 Million	379,593 New	379,593 $7.6 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.